Rapamycin resistance tied to defective regulation of p27Kip1.

Molecular and Cellular Biology
Y LuoA R Marks

Abstract

The potent antiproliferative activity of the macrolide antibiotic rapamycin is known to involve binding of the drug to its cytosolic receptor, FKBP12, and subsequent interaction with targets of rapamycin, resulting in inhibition of p70 S6 kinase (p70S6K). However, the downstream events that lead to inhibition of cell cycle progression remain to be elucidated. The antiproliferative effects of rapamycin are associated with prevention of mitogen-induced downregulation of the cyclin-dependent kinase inhibitor p27Kip1, suggesting that the latter may play an important role in the growth pathway targeted by rapamycin. Murine BC3H1 cells, selected for resistance to growth inhibition by rapamycin, exhibited an intact p70S6K pathway but had abnormally low p27 levels that were no longer responsive to mitogens or rapamycin. Fibroblasts and T lymphocytes from mice with a targeted disruption of the p27Kip1 gene had impaired growth-inhibitory responses to rapamycin. These results suggest that the ability to regulate p27Kip1 levels is important for rapamycin to exert its antiproliferative effects.

References

Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J A DeCaprioD M Livingston
May 1, 1974·The Journal of Cell Biology·D SchubertS Heinemann
Nov 17, 1995·The Journal of Biological Chemistry·M C Lorenz, J Heitman
Oct 5, 1995·Nature·E J BrownS L Schreiber
May 15, 1995·Genes & Development·C J Sherr, J M Roberts
Mar 9, 1995·Nature·D O Morgan
Dec 1, 1994·Molecular and Cellular Biology·B Shan, W H Lee
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·X Q QinP D Adams
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·X Wu, A J Levine
Apr 1, 1993·Genes & Development·M Debbas, E White
May 13, 1993·Nature·H A LaneG Thomas
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·L CheathamJ Blenis
Dec 1, 1995·Current Opinion in Cell Biology·M M Chou, J Blenis
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·M H LeeJ Massagué

❮ Previous
Next ❯

Citations

Sep 23, 2006·Expert Opinion on Investigational Drugs·Piotr Smolewski
Mar 11, 2005·Expert Opinion on Emerging Drugs·Pierre-Frédéric KellerJean-Claude Tardif
Feb 25, 2006·The Canadian Journal of Cardiology·Thierry CharronBradley H Strauss
Apr 19, 2011·Current Opinion in Pharmacology·Arturo Giordano, Alfredo Romano
May 12, 2010·Prostaglandins & Other Lipid Mediators·Paola CastagninoRichard K Assoian
May 8, 2009·Trends in Cell Biology·Xuemin Wang, Christopher G Proud
Feb 25, 2009·Current Opinion in Cell Biology·David R Plas, George Thomas
Jul 29, 2008·Current Problems in Cancer·Isam A Abdel-Karim, Francis J Giles
Mar 22, 2005·British Journal of Pharmacology·Elaine M BreslinPaul Brennan
Dec 18, 2013·Immunological Reviews·Daniel H Fowler
Jun 8, 2006·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Ilona SilinsUlla Stenius
Feb 2, 2006·European Journal of Pharmacology·Tom J ParryRonald J Tallarida
Nov 8, 2005·European Journal of Pharmacology·Tom J ParryJohn Siekierka
Jul 26, 2005·Critical Reviews in Oncology/hematology·Brian K Law
Feb 5, 2002·Expert Opinion on Pharmacotherapy·B D Kahan
Feb 21, 2006·Journal of the American College of Cardiology·Rainer WesselyAdnan Kastrati
Feb 1, 2014·Biochimica Et Biophysica Acta·Matteo SantoniStefano Cascinu
Oct 24, 2007·Journal of Vascular Surgery·Seung-Kee MinAlexander W Clowes
Nov 19, 2003·Mechanisms of Development·Thomas P Neufeld
May 14, 1999·Chemistry & Biology·F G Kuruvilla, S L Schreiber
May 18, 2001·Blood Cells, Molecules & Diseases·J GonzalezM B Prystowsky
Jan 30, 2004·Annual Review of Medicine·T Cooper Woods, Andrew R Marks
Sep 10, 1998·Journal of the National Cancer Institute·C Cordon-CardoH I Scher
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·K PodsypaninaR Parsons
Jun 7, 2006·Proceedings of the National Academy of Sciences of the United States of America·Philip Downey
Jun 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alex A Adjei, Manuel Hidalgo
Apr 9, 2015·Scientific Reports·Wu ZhangJiang Zhu
May 10, 2017·Proceedings of the National Academy of Sciences of the United States of America·Bogdan BeirowskiJeffrey Milbrandt
Feb 17, 2007·Molecular Microbiology·Vittoria ZinzallaLilia Alberghina
May 13, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Raja KandaswamyArthur J Matas
Sep 6, 2006·British Journal of Cancer·R T KurmashevaP J Houghton
Oct 3, 2003·The New England Journal of Medicine·Andrew R Marks
Jan 1, 2012·Pharmaceuticals·Evangelos G SarrisKostas N Syrigos
Oct 17, 2001·Transplantation·B D Kahan, J S Camardo
Apr 20, 2004·Oncogene·Eric C HollandGeorge Thomas
May 15, 2004·DNA and Cell Biology·Shohreh AminiBassel E Sawaya
Nov 17, 2009·World Journal of Gastroenterology : WJG·Marcela KopacovaJan Bures
Jan 12, 2000·The Journal of Cell Biology·K J HarveyD S Ucker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.